不同手术入路腹腔镜辅助经肛门括约肌间切除术治疗低位直肠癌的临床疗效

Clinical efficacy of laparoscopic-assisted intersphincteric resection with different surgical approaches for low rectal cancer

  • 摘要:
    目的 探讨不同手术入路腹腔镜辅助经肛门括约肌间切除术(ISR)治疗低位直肠癌的临床疗效。
    方法 采用回顾性队列研究方法。收集2016年1月至2020年12月福建医科大学附属第二医院收治的90例低位直肠癌患者的临床病理资料;男58例,女32例;年龄为(60±9)岁。90例患者中,60例行经盆腔入路腹腔镜辅助ISR,30例行混合入路(经腹和经肛门)腹腔镜辅助ISR。观察指标:(1)经盆腔入路和混合入路患者临床病理特征。(2)经盆腔入路和混合入路患者术中及术后情况。(3)经盆腔入路和混合入路患者术后并发症情况。(4)随访情况。采用电话、门诊等方式进行随访,术后3年内每3个月随访1次,术后3~5年每半年随访1次,术后5年后每年随访1次,了解患者肿瘤复发、转移及生存情况。随访时间截至2021年3月或患者死亡。正态分布的计量资料以x±s表示,组间比较采用t检验。偏态分布的计量资料以M(范围)表示,组间比较采用非参数Mann⁃Whitney U检验。计数资料以绝对数或百分比表示,组间比较采用χ²检验或Fisher确切概率法。等级资料比较采用非参数秩和检验。采用Kaplan‑Meier法绘制生存曲线并计算生存率,Log‑Rank检验进行生存分析。
    结果 (1)经盆腔入路和混合入路患者临床病理特征。经盆腔入路和混合入路患者性别(男、女)分别为34、26例和24、6例,肿瘤下缘距肛缘距离分别为(4.5±0.5)cm和(3.5±0.5)cm,两者上述指标比较,差异均有统计学意义(χ²=4.75,t=8.35,P<0.05)。(2)经盆腔入路和混合入路患者术中及术后情况。经盆腔入路和混合入路患者手术时间、术中出血量、术后吻合口距肛缘距离分别为(187±9)min、50(20~200)mL、(3.4±0.7)cm和(256±12)min、100(20~200)mL、(2.6±0.7)cm;两者上述指标比较,差异均有统计学意义(t=-26.99,Z=-2.48,t=4.67,P<0.05)。两者均无远切缘阳性患者。经盆腔入路和混合入路患者造口还纳率分别为93.3%(56/60)和90.0%(27/30)。60例经盆腔入路患者中,3例因吻合口并发症未行造口还纳,1例未到造口还纳时间;30例混合入路患者中,2例因吻合口并发症未行造口还纳,1例未到造口还纳时间。经盆腔入路和混合入路患者行造口还纳后1个月、3个月Wexner评分分别为15(12~17)分、12(10~14)分和16(14~18)分、14(12~16)分;两者上述指标比较,差异均有统计学意义(Z=-4.97,-5.49,P<0.05)。经盆腔入路和混合入路患者行造口还纳后6个月Wexner评分分别为10(9~12)分和11(8~12)分,两者比较,差异无统计学意义(Z=-1.59,P>0.05)。(3)经盆腔入路和混合入路患者术后并发症情况。经盆腔入路和混合入路患者术后总并发症分别为16例和9例,两者比较,差异无统计学意义(χ²=0.11,P>0.05);两种入路患者术后吻合口瘘、吻合口出血、吻合口狭窄、肠梗阻、切口感染、尿潴留、盆腔感染、肺部感染、切口疝、乳糜瘘、腹盆腔脓肿分别为5、2、1、7、0、1、5、3、1、1、1例和6、3、2、2、2、1、2、3、1、1、1例,两者上述指标比较,差异均无统计学意义(P>0.05)。同一例患者可合并多种术后并发症。(4)随访情况。90例患者均获得随访,随访时间为27(6~62)个月。60例经盆腔入路患者随访时间为27(8~62)个月;30例经混合入路患者随访时间为28(6~53)个月。60例经盆腔入路患者中,3例局部复发、4例肝转移、3例肺转移,均带瘤生存;30例混合入路患者中,1例局部复发、2例肝转移、1例肺转移,均带瘤生存;均无死亡患者。经盆腔入路和混合入路患者3年无病生存率分别为84.7%和87.9%,两者比较,差异无统计学意义(χ²=0.39,P>0.05)。
    结论 经盆腔入路和混合入路行腹腔镜辅助ISR治疗低位直肠癌均安全、可行。与混合入路比较,经盆腔入路腹腔镜辅助ISR手术时间更短,术中出血量更少,术后吻合口距肛缘距离更长。

     

    Abstract:
    Objective To investigate the clinical efficacy of laparoscopic-assisted inters-phincteric resection (ISR) with different surgical approaches for low rectal cancer.
    Methods The retrospective cohort study was conducted. The clinicopathological data of 90 patients with low rectal cancer who were admitted to the Second Affiliated Hospital of Fujian Medical University from January 2016 to December 2020 were collected. There were 58 males and 32 females, aged (60±9)years. Of 90 patients, 60 cases underwent laparoscopic assisted ISR with transpelvic approach, 30 cases underwent laparoscopic assisted ISR with transabdominal and transanal mixed approach. Observation indicators: (1) clinicopathological characteristics of patients with transpelvic approach and mixed approach; (2) intraoperative and postoperative conditions of patients with transpelvic approach and mixed approach; (3) postoperative complications of patients with transpelvic approach and mixed approach; (4) follow-up. Follow-up was conducted by telephone interview and outpatient examination once every 3 months within postoperative 3 years, once every six months in the postoperative 3 to 5 years and once a year after postoperative 5 years to detect tumor recurrence and metastasis, and survival of patients.Follow-up was up to March 2021 or patient death. Measurement data with normal distribution were represented as Mean±SD, and the t test was used for comparison between groups. Measurement data with skewed distribution were expressed as M(range), and comparison between groups was conducted using the non-parametric Mann-Whitney U test. Count data were expressed as absolute numbers or percentages, and comparison between groups was performed using the chi-square test or Fisher exact probability. Comparison of ordinal data was analyzed by the non-parametric rank sum test. Kaplan-Meier method was used to draw survival curves and calculate survival rates, and survival analysis was performed by the Log-Rank test.
    Results (1) Clinicopathological characteristics of patients with transpelvic approach and mixed approach. The sex (males, females), distance from the distal margin of tumor to anal margin were 34, 26, (4.5±0.5)cm for patients with transpelvic approach, versus 24, 6, (3.5±0.5)cm for patients with mixed approach, respectively, showing significant differences between them (χ2=4.75, t=8.35, P<0.05). (2) Intraoperative and postoperative conditions of patients with transpelvic approach and mixed approach. The operation time, volume of intraoperative blood loss, distance from the postoperative anastomosis to anal margin were (187±9)minutes, 50(range, 20‒200)mL, (3.4±0.7)cm for patients with transpelvic approach, versus (256±12)minuets, 100(range, 20‒200)mL, (2.6±0.7)cm for patients with mixed approach, showing significant differences between them (t=‒26.99, Z=‒2.48, t=4.67, P<0.05). None of the 90 patients had a positive distal margin. The stoma reversal rates of patients with transpelvic and mixed approach were 93.3%(56/60) and 90.0%(27/30), respectively. Of the 60 patients with transpelvic approach, 3 cases had no stoma reversal due to anastomotic complications, and 1 case was not yet to the reversal time. Of the 30 patients with mixed approach, 2 cases had no stoma reversal due to anastomotic complications, and 1 case was not yet to the reversal time. The 1-, 3-month Wexner scores after stoma reversal were 15(range, 12‒17), 12(range, 10‒14) for patients with transpelvic approach, versus 16(range, 14‒18), 14(range, 12‒16) for patients with mixed approach, showing significant differences between them (Z=‒4.97, ‒5.49, P<0.05). The 6-month Wexner score after stoma reversal was 10(range, 9‒12) for patients with transpelvic approach, versus 11(range, 8‒12) for patients with mixed approach, showing no significant difference between them (Z=‒1.59, P>0.05). (3) Postoperative complications of patients with transpelvic approach and mixed approach. The complications occurred to 16 patients with transpelvic approach and 9 patients with mixed approach, respectively, showing no significant difference between them (χ2=0.11, P>0.05). Cases with postoperative anastomotic fistula, cases with anastomotic bleeding, cases with anastomotic stenosis, cases with intestinal obstruction, cases with incision infection, cases with urinary retention, cases with pelvic infection, cases with pulmonary infection, cases with incisional hernia, cases with chylous fistula, cases with abdominal and pelvic abscess were 5, 2, 1, 7, 0, 1, 5, 3, 1, 1, 1 for patients with transpelvic approach, versus 6, 3, 2, 2, 2, 1, 2, 3, 1, 1, 1 for patients with mixed approach, showing no significant difference between them (P>0.05). The same patient could have multiple postoperative complications. (4) Follow-up. All the 90 patients were followed up for 27(range, 6‒62)months. The follow-up time of 60 patients with transpelvic approach was 27(range, 8‒62)months. The follow-up time of 30 patients with mixed approach was 28(range, 6‒53)months. Of the 60 patients with transpelvic approach, 3 cases had local recurrence, 4 cases had liver metastasis, 3 cases had lung metastasis, and all of them survived with tumor. Of the 30 patients with mixed approach, 1 case had local recurrence, 2 cases had liver metastasis, 1 case had lung metastasis, and all of them survived with tumor. There was no death. The 3-year disease-free survival rates of patients with transpelvic approach and mixed approach were 84.7% and 87.9%, respectively, showing no significant difference between them (χ2=0.39, P>0.05).
    Conclusions Lapa-roscopic assisted ISR via transpelvic approach or mixed approach for low rectal cancer are safe and feasible. Compared with transanal mixed approach, the transpelvic approach of laparoscopic-assisted ISR has shorter operation time, less volume of intraoperative blood loss and longer distance from the postoperative anastomosis to anal margin.

     

/

返回文章
返回